Assessing the efficacy and safety of STOP (successful treatment for paranoia)—an app-based cognitive bias modification therapy for paranoia: a randomised clinical trial protocol
Jenny Yiend,Rayan Taher,Carolina Fialho,Chloe Hampshire,Che-Wei Hsu,Thomas Kabir,Jeroen Keppens,Philip McGuire,Elias Mouchlianitis,Emmanuelle Peters,Tanya Ricci,Sukhwinder Shergill,Daniel Stahl,George Vamvakas,Pamela Jacobsen,the MPIT,AI Richards,Alex Kenny,Edmund Brooks,Emily Curtis,Vanessa Pinfold,Avegen,Nandita Kurup,Neeraj Apte,Neha Gupta
DOI: https://doi.org/10.1186/s13063-024-08570-3
IF: 2.728
2024-12-04
Trials
Abstract:Paranoia, the belief that you are at risk of significant physical or emotional harm from others, is a common difficulty, which causes significant distress and impairment to daily functioning, including in psychosis-spectrum disorders. According to cognitive models of psychosis, paranoia may be partly maintained by cognitive processes, including interpretation biases. Cognitive bias modification for paranoia (CBM-pa) is an intervention targeting the bias towards interpreting ambiguous social scenarios in a way that is personally threatening. This study aims to test the efficacy and safety of a mobile app version of CBM-pa, called STOP (successful treatment of paranoia).
medicine, research & experimental